SCHEMBL17023097

SCHEMBL17023097

Cc1cccc(C)c1-c1ccc(OC(=O)Nc2ccc(CN3CCN(C)CC3)cn2)c2nccnc12

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 18/20 0.59
F10 P00742 1/20 0.41
BTK Q06187 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17023075 0.87 FGFR3 (0.54) FGFR3F10
SCHEMBL12678318 0.86 FGFR3 (0.72) FGFR3F10
SCHEMBL17023017 0.86 FGFR3 (0.65) FGFR3BTK
SCHEMBL17023084 0.86 FGFR3 (0.79) FGFR3
SCHEMBL17023100 0.85 FGFR3 (0.80) FGFR3
SCHEMBL17023052 0.83 FGFR3 (0.57) FGFR3F10
SCHEMBL17023126 0.83 FGFR3 (0.77) FGFR3F10
SCHEMBL17023041 0.82 FGFR3 (0.81) FGFR3
SCHEMBL17023046 0.80 FGFR3 (0.42) FGFR3
SCHEMBL17023047 0.80 FGFR3 (0.70) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed